These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 23982524)

  • 21. [Immunotherapy of melanomas].
    Zimmer L; Vaubel J; Schadendorf D
    Hautarzt; 2012 Dec; 63(12):952-8. PubMed ID: 23097082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
    Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
    [No Abstract]   [Full Text] [Related]  

  • 23. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
    Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D; ;
    J Dtsch Dermatol Ges; 2013 Aug; 11 Suppl 6():1-116, 1-126. PubMed ID: 24028775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
    J Clin Oncol; 2018 Feb; 36(4):399-413. PubMed ID: 29232171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Criteria for Critical Care Infants and Children: PICU Admission, Discharge, and Triage Practice Statement and Levels of Care Guidance.
    Frankel LR; Hsu BS; Yeh TS; Simone S; Agus MSD; Arca MJ; Coss-Bu JA; Fallat ME; Foland J; Gadepalli S; Gayle MO; Harmon LA; Hill V; Joseph CA; Kessel AD; Kissoon N; Moss M; Mysore MR; Papo ME; Rajzer-Wakeham KL; Rice TB; Rosenberg DL; Wakeham MK; Conway EE;
    Pediatr Crit Care Med; 2019 Sep; 20(9):847-887. PubMed ID: 31483379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma.
    McDermott D; Lebbé C; Hodi FS; Maio M; Weber JS; Wolchok JD; Thompson JA; Balch CM
    Cancer Treat Rev; 2014 Oct; 40(9):1056-64. PubMed ID: 25060490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Initial evaluation, diagnosis, staging, treatment, and follow-up of patients with primary cutaneous malignant melanoma. Consensus statement of the Network of Catalan and Balearic Melanoma Centers].
    Mangas C; Paradelo C; Puig S; Gallardo F; Marcoval J; Azon A; Bartralot R; Bel S; Bigatà X; Curcó N; Dalmau J; del Pozo LJ; Ferrándiz C; Formigón M; González A; Just M; Llambrich A; Llistosella E; Malvehy J; Martí RM; Nogués ME; Pedragosa R; Rocamora V; Sàbat M; Salleras M
    Actas Dermosifiliogr; 2010 Mar; 101(2):129-42. PubMed ID: 20223155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional
    Da Gama Duarte J; Parakh S; Andrews MC; Woods K; Pasam A; Tutuka C; Ostrouska S; Blackburn JM; Behren A; Cebon J
    Front Immunol; 2018; 9():411. PubMed ID: 29552014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy.
    Queirolo P; Marincola F; Spagnolo F
    Arch Dermatol Res; 2014 Aug; 306(6):521-6. PubMed ID: 24682537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical practice consensus for the diagnosis and management of melanoma in Taiwan.
    Wu CE; Liao YH; Wu CL; Yen RF; Lin CC; Yang MH; Yen CC; Su WC; Yen CJ; Chang YF; Wu MF; Yang Y; Lin CY; Yang WC; Wang HC; Li CY; Ho YY; Chang YY; Wu CS; Hsu HC; Chen KH; Huang Y; Chen CJ; Chuang PJ; Lai YC; Huang YY; Tseng NC; Huang YT; Chu CY; Wen-Cheng Chang J
    J Formos Med Assoc; 2024 Jan; 123(1):7-15. PubMed ID: 37690868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy in managing metastatic melanoma: which treatment when?
    Amaral T; Meraz-Torres F; Garbe C
    Expert Opin Biol Ther; 2017 Dec; 17(12):1523-1538. PubMed ID: 28891339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy.
    Lee N; Zakka LR; Mihm MC; Schatton T
    Pathology; 2016 Feb; 48(2):177-87. PubMed ID: 27020390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment.
    Leon-Mateos L; Garcia-Velloso MJ; García-Figueiras R; Rodriguez-Moreno JF; Vercher-Conejero JL; Sánchez M; Perez Gracia JL; Simo-Perdigo M; Gorospe L
    Clin Transl Oncol; 2021 Mar; 23(3):434-449. PubMed ID: 32623581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methodology for development of guidelines for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Lewis SZ; Diekemper R; Addrizzo-Harris DJ
    Chest; 2013 May; 143(5 Suppl):41S-50S. PubMed ID: 23649432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma as a model tumour for immuno-oncology.
    Maio M
    Ann Oncol; 2012 Sep; 23 Suppl 8():viii10-4. PubMed ID: 22918922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].
    Leccia MT; Planchamp F; Sassolas B; Combemale P; Modiano P; Bedane C; Cupissol D; Derrey S; Dygai-Cochet I; Lamant L; Lubrano V; Mirabel X; Mourrégot A; Rougé Bugat ME; Siegrist S; Thariat J; Tiffet O; Truc G; Verdoni L; Mazeau-Woynar V
    Ann Dermatol Venereol; 2014 Feb; 141(2):111-21. PubMed ID: 24507205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (Neo)adjuvant systemic therapy for melanoma.
    van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
    Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews.
    Livingstone A; Dempsey K; Stockler MR; Howard K; Long GV; Carlino MS; Menzies AM; Morton RL
    BMC Cancer; 2021 Sep; 21(1):1014. PubMed ID: 34507552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy of melanoma: present options and future promises.
    Rotte A; Bhandaru M; Zhou Y; McElwee KJ
    Cancer Metastasis Rev; 2015 Mar; 34(1):115-28. PubMed ID: 25589384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy.
    Wyluda EJ; Cheng J; Schell TD; Haley JS; Mallon C; Neves RI; Robertson G; Sivik J; Mackley H; Talamo G; Drabick JJ
    Cancer Biol Ther; 2015; 16(5):662-70. PubMed ID: 25806780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.